What is the role of stellectomy in the treatment of long QT syndrome (LQTS)?

Updated: Nov 29, 2017
  • Author: Ali A Sovari, MD, FACP, FACC; Chief Editor: Mikhael F El-Chami, MD  more...
  • Print
Answer

Left cervicothoracic stellectomy is another antiadrenergic therapeutic measure used in high-risk patients with long QT syndrome (LQTS), especially in those with recurrent cardiac events despite beta-blocker therapy.

Stellectomy decreases the risk of cardiac events in high-risk patients with LQTS, although it is more effective in patients with LQT1 than in those with other types of LQTS.

Although this technique decreases the risk of cardiac events, it does not eliminate the risk. Therefore, the use of an implantable cardioverter-defibrillator (ICD) is superior to cervicothoracic stellectomy. However, cervicothoracic stellectomy may be indicated in some high-risk patients and in patients who have several ICD discharges while being treated with beta blockade and an ICD.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!